Edition:
United Kingdom

People: Prometic Life Sciences Inc (PLI.TO)

PLI.TO on Toronto Stock Exchange

0.05CAD
18 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.05
Open
$0.05
Day's High
$0.05
Day's Low
$0.05
Volume
8,872,060
Avg. Vol
2,139,448
52-wk High
$1.01
52-wk Low
$0.05

Pritchard, Bruce 

Mr. Bruce Pritchard is Interim Chief Financial Officer, Chief Operating Officer of the Company. Mr. Bruce Pritchard joined PLI as CFO of the UK subsidiary, Prometic BioSciences Ltd. (“PBL”) in 2006 and was promoted CFO of the group in 2008, relinquishing that post in November 2015. He became Chief Operating Officer in August 2014. He is a chartered accountant with many years of experience in general management, operations and corporate accountancy including senior finance positions with biotech and pharmaceutical companies. He has a proven track record of success in strategic acquisitions and in raising debt and equity finance. Mr. Pritchard is a Non-Executive Director and Chair of the Audit Committee of Imanova Limited. A Heriot-Watt University graduate, Mr. Pritchard gained a BA in Accountancy and Computer Science in 1993, he qualified as a Member of the Institute of Chartered Accountants of Scotland in 1996. He was appointed a Fellow of the Institute of Directors in 2014.

Basic Compensation

Total Annual Compensation, CAD 903,171
Restricted Stock Award, CAD 1,497,190
Long-Term Incentive Plans, CAD --
All Other, CAD 311,216
Fiscal Year Total, CAD 2,711,580

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Simon Best

277,333

Bruce Pritchard

2,711,580

John Moran

1,837,760

Bruce Wendel

121,072

Patrick Sartore

2,119,760

Stefan Clulow

121,072
As Of  31 Dec 2017